Umbilical Cord-Derived Mesenchymal Stem Cells (UC-MSCs) therapy (Universitas Diponegoro)

N/A

Report date: 2025/06/10 20:00:09
NME

Base Information

Drug NameUmbilical Cord-Derived Mesenchymal Stem Cells (UC-MSCs) therapy (Universitas Diponegoro)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsUpdating
Therapy Area/IndicationsLiver DysfunctionLiver CirrhosisBiliary Atresia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndonesia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversitas Diponegoro
China Registration ClassN/A

Develop Information

Active CompaniesUniversitas Diponegoro
Inactive CompaniesN/A
Active IndicationsLiver DysfunctionLiver CirrhosisBiliary Atresia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A